U.S. stocks closed higher Friday, capping a choppy week of trading with the market's third winning week in the last four and ...

NasdaqGS:GILD 1 Year Share Price vs Fair Value Explore Gilead Sciences's Fair Values from the Community and ...

We recently published 10 Stocks with Eye-Popping Gains; 5 Jump to New Highs. Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best-performing stocks on Friday. Gilead Sciences jumped to a new ...

At the open, the Dow Jones Industrial Average rose 76.3 points, or 0.17%, to 44044.95. The S&P 500 rose 15.2 points, or 0.24%, to 6355.22, while the Nasdaq Composite rose 73.7 points, or 0.35%, to ...

The Dow Jones Industrial Average rose 259.17 points, or 0.59%, to 44,227.81, the S&P 500 gained 52.39 points, or 0.83%, to 6,392.39 and the Nasdaq Composite gained 200.15 points, or 0.94%, to ...

The TSX Composite Index recovered 56.26 points by noon EDT Friday to 27,817.53. In a holiday-shortened week, the index climbed 797 points, or 2.95%. The Canadian dollar dipped 0.11 cents to 72.70 ...

Detailed price information for Royalty Pharma Plc Cl A (RPRX-Q) from The Globe and Mail including charting and trades.

Stocks saw their best week since June, with a rally in big tech driving the Nasdaq 100 to all-time highs. Also buoying ...

In a report released today, Joseph Stringer from Needham maintained a Buy rating on Cidara Therapeutics, with a price target of $74.00. The company’s shares closed yesterday at $61.73. Take advantage ...